Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas D Coates

Showing results (141-150 of 147) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 147 results.
Pediatric Blood & Cancer|September 12, 2022
Consensus definition of essential, optimal, and suggested components of a pediatric sickle cell disease centerMonica L Hulbert, Deepa Manwani, Emily Riehm Meier, et al.
Haematologica|April 16, 2026
Immunosuppressive therapy for severe aplastic anemia in children under the age of 3 years yields a high response rate: a North American collaborative studyTalya Wittmann Dayagi, Laura Willis, Staci D Arnold, et al.
The Lancet. Haematology|February 13, 2025
Long-term efficacy and safety of luspatercept for the treatment of anaemia in patients with transfusion-dependent β-thalassaemia (BELIEVE): final results from a phase 3 randomised trialMaria Domenica Cappellini, Vip Viprakasit, Pencho Georgiev, et al.
The Lancet. Haematology|August 25, 2022
Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trialAli T Taher, Maria Domenica Cappellini, Antonis Kattamis, et al.
The Journal of Clinical Investigation|July 19, 2013
β-globin gene transfer to human bone marrow for sickle cell diseaseZulema Romero, Fabrizia Urbinati, Sabine Geiger, et al.
Haematologica|April 6, 2019
Immunosuppressive therapy for pediatric aplastic anemia: a North American Pediatric Aplastic Anemia Consortium studyZora R Rogers, Taizo A Nakano, Timothy S Olson, et al.
Annals of the American Thoracic Society|August 31, 2019
Identifying Clinical and Research Priorities in Sickle Cell Lung Disease. An Official American Thoracic Society Workshop ReportA Parker Ruhl, S Christy Sadreameli, Julian L Allen, et al.
Pageof 15

Showing results (141-150 of 147) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 147 results.
Pediatric Blood & Cancer|September 12, 2022
Consensus definition of essential, optimal, and suggested components of a pediatric sickle cell disease centerMonica L Hulbert, Deepa Manwani, Emily Riehm Meier, et al.
Haematologica|April 16, 2026
Immunosuppressive therapy for severe aplastic anemia in children under the age of 3 years yields a high response rate: a North American collaborative studyTalya Wittmann Dayagi, Laura Willis, Staci D Arnold, et al.
The Lancet. Haematology|February 13, 2025
Long-term efficacy and safety of luspatercept for the treatment of anaemia in patients with transfusion-dependent β-thalassaemia (BELIEVE): final results from a phase 3 randomised trialMaria Domenica Cappellini, Vip Viprakasit, Pencho Georgiev, et al.
The Lancet. Haematology|August 25, 2022
Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trialAli T Taher, Maria Domenica Cappellini, Antonis Kattamis, et al.
The Journal of Clinical Investigation|July 19, 2013
β-globin gene transfer to human bone marrow for sickle cell diseaseZulema Romero, Fabrizia Urbinati, Sabine Geiger, et al.
Haematologica|April 6, 2019
Immunosuppressive therapy for pediatric aplastic anemia: a North American Pediatric Aplastic Anemia Consortium studyZora R Rogers, Taizo A Nakano, Timothy S Olson, et al.
Annals of the American Thoracic Society|August 31, 2019
Identifying Clinical and Research Priorities in Sickle Cell Lung Disease. An Official American Thoracic Society Workshop ReportA Parker Ruhl, S Christy Sadreameli, Julian L Allen, et al.
Pageof 15